Want create site? Find Free WordPress Themes and plugins.



Global Peptide Therapeutics Sales Market Report 2018

Single User- USD4000Multi User-USD8000
Number of Pages-195Number of Figures252

Choose License Type:


Clear


Description

Want create site? Find Free WordPress Themes and plugins.

This report studies the Peptide Therapeutics market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Peptide Therapeutics market by product type and applications.

In the last several years, global market of Peptide Therapeutics developed rapidly, with an average growth rate of 7.7%. In 2017, global revenue of Peptide Therapeutics is nearly 28.5 billion USD; the actual production is about 150 million units.

The major players in global Peptide Therapeutics market include
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
Shire
AbbVie
Ipsen
Allergan
Ferring
Merck
The Medicines
Roche
J & J

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Peptide Therapeutics in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
India
South America
Rest of World

On the basis of product, the Peptide Therapeutics market is primarily split into
Injection
Oral
Other

On the basis on the end users/applications, this report covers
Cancer
Metabolic Disorders
Central Nervous System
Other

Did you find apk for android? You can find new Free Android Games and apps.

Table of Content

Want create site? Find Free WordPress Themes and plugins.

Table of Contents

1 Peptide Therapeutics Market Overview 1
1.1 Product Overview and Scope of Peptide Therapeutics 1
1.2 Classification of Peptide Therapeutics by Product Category 3
1.2.1 Global Peptide Therapeutics Revenue Comparison by Types (2013-2025) 3
1.2.2 Global Peptide Therapeutics Revenue Market Share by Types in 2017 3
1.2.3 Injection 4
1.2.4 Oral 4
1.3 Global Peptide Therapeutics Market by Applications/End Users 5
1.3.1 Global Peptide Therapeutics Revenue Comparison by Applications (2013-2025) 5
1.3.2 Cancer 6
1.3.3 Metabolic Disorders 6
1.3.4 Central Nervous System 7
1.4 Global Peptide Therapeutics Market by Regions 7
1.4.1 Global Peptide Therapeutics Revenue Comparison by Regions (2013-2025) 7
1.4.2 North America Peptide Therapeutics Status and Prospect (2013-2025) 8
1.4.3 Europe Peptide Therapeutics Status and Prospect (2013-2025) 9
1.4.4 China Peptide Therapeutics Status and Prospect (2013-2025) 10
1.4.5 Japan Peptide Therapeutics Status and Prospect (2013-2025) 11
1.4.6 India Peptide Therapeutics Status and Prospect (2013-2025) 12
1.4.7 South America Peptide Therapeutics Status and Prospect (2013-2025) 13
1.5 Global Peptide Therapeutics Sales and Revenue (2013-2025) 14
1.5.1 Global Peptide Therapeutics Sales and Growth Rate (2013-2025) 14
1.5.2 Global Peptide Therapeutics Revenue and Growth Rate (2013-2025) 15
1.6 Lanreotide Revenue and Growth Rate2013-2025 15
1.7 Liraglutide Revenue and Growth Rate 2013-2025 16
2 Global Peptide Therapeutics Competition by Players, Type and Application 17
2.1 Global Peptide Therapeutics Market Competition by Players 17
2.1.1 Global Peptide Therapeutics Sales and Market Share of Key Players (2016-2017) 17
2.1.2 Global Peptide Therapeutics Revenue and Share by Players (2016-2017) 20
2.2 Global Peptide Therapeutics Sales and Revenue by Type 24
2.2.1 Global Peptide Therapeutics Sales and Market Share by Type (2013-2018) 24
2.2.2 Global Peptide Therapeutics Revenue and Market Share by Type (2013-2018) 26
2.3 Global Peptide Therapeutics Sales and Revenue by Regions 27
2.3.1 Global Peptide Therapeutics Sales and Market Share by Regions (2013-2018) 27
2.3.2 Global Peptide Therapeutics Revenue and Market Share by Regions (2013-2018) 29
2.4 Global Peptide Therapeutics Revenue by Application 31
3 North America Peptide Therapeutics (Sales, Revenue and Price) 34
3.1 North America Peptide Therapeutics Sales and Revenue (2013-2018) 34
3.1.1 North America Peptide Therapeutics Sales and Growth Rate (2013-2018) 34
3.1.2 North America Peptide Therapeutics Revenue and Growth Rate (2013-2018) 35
3.1.3 North America Peptide Therapeutics Price Trend (2013-2018) 36
3.2 North America Peptide Therapeutics Revenue and Market Share by Players 36
3.3 North America Peptide Therapeutics Revenue and Market Share by Type 38
3.4 North America Peptide Therapeutics Revenue and Market Share by Application 39
4 China Peptide Therapeutics (Sales, Revenue and Price) 41
4.1 China Peptide Therapeutics Sales and Revenue (2013-2018) 41
4.1.1 China Peptide Therapeutics Sales and Growth Rate (2013-2018) 41
4.1.2 China Peptide Therapeutics Revenue and Growth Rate (2013-2018) 42
4.1.3 China Peptide Therapeutics Price Trend (2013-2018) 42
4.2 China Peptide Therapeutics Revenue and Market Share by Players 43
4.3 China Peptide Therapeutics Revenue and Market Share by Type 44
4.4 China Peptide Therapeutics Revenue and Market Share by Application 45
5 Europe Peptide Therapeutics (Sales, Revenue and Price) 47
5.1 Europe Peptide Therapeutics Sales and Value (2013-2018) 47
5.1.1 Europe Peptide Therapeutics Sales and Growth Rate (2013-2018) 47
5.1.2 Europe Peptide Therapeutics Revenue and Growth Rate (2013-2018) 48
5.1.3 Europe Peptide Therapeutics Price Trend (2013-2018) 48
5.2 Europe Peptide Therapeutics Revenue and Market Share by Players 49
5.3 Europe Peptide Therapeutics Revenue and Market Share by Type 50
5.4 Europe Peptide Therapeutics Revenue and Market Share by Application 52
6 Japan Peptide Therapeutics (Sales, Revenue and Price) 54
6.1 Japan Peptide Therapeutics Sales and Value (2013-2018) 54
6.1.1 Japan Peptide Therapeutics Sales and Growth Rate (2013-2018) 54
6.1.2 Japan Peptide Therapeutics Revenue and Growth Rate (2013-2018) 55
6.1.3 Japan Peptide Therapeutics Price Trend (2013-2018) 55
6.2 Japan Peptide Therapeutics Revenue and Market Share by Players 56
6.3 Japan Peptide Therapeutics Revenue and Market Share by Type 57
6.4 Japan Peptide Therapeutics Revenue and Market Share by Application 58
7 India Peptide Therapeutics (Sales, Revenue and Price) 60
7.1 India Peptide Therapeutics Sales and Value (2013-2018) 60
7.1.1 India Peptide Therapeutics Sales and Growth Rate (2013-2018) 60
7.1.2 India Peptide Therapeutics Revenue and Growth Rate 61
7.1.3 India Peptide Therapeutics Price Trend 61
7.2 India Peptide Therapeutics Revenue and Market Share by Players 62
7.3 India Peptide Therapeutics Revenue and Market Share by Type 63
7.4 India Peptide Therapeutics Revenue and Market Share by Application 64
8 South America Peptide Therapeutics (Sales, Revenue and Price) 66
8.1 South America Peptide Therapeutics Sales and Value (2013-2018) 66
8.1.1 South America Peptide Therapeutics Sales and Growth Rate (2013-2018) 66
8.1.2 South America Peptide Therapeutics Revenue and Growth Rate (2013-2018) 67
8.1.3 South America Peptide Therapeutics Price Trend 67
8.2 South America Peptide Therapeutics Revenue and Market Share by Players 68
8.3 South America Peptide Therapeutics Revenue and Market Share by Type 69
8.4 South America Peptide Therapeutics Revenue and Market Share by Application 70
9 Analysis of Peptide Therapeutics Industry Key Manufacturers 72
9.1 Sanofi 72
9.1.1 Company Profile 72
9.1.2 Product Information 73
9.1.3 Sales, Price, Cost, Gross, and Revenue 73
9.2 Teva 74
9.2.1 Company Profile 74
9.2.2 Product Information 75
9.2.3 Sales, Price, Cost, Gross, and Revenue 75
9.3 Novo Nordisk 76
9.3.1 Company Profile 76
9.3.2 Product Information 77
9.3.3 Sales, Price, Cost, Gross, and Revenue 77
9.4 Takeda 77
9.4.1 Company Profile 77
9.4.2 Product Information 79
9.4.3 Sales, Price, Cost, Gross, and Revenue 79
9.5 Eli Lilly 80
9.5.1 Company Profile 80
9.5.2 Product Information 81
9.5.3 Sales, Price, Cost, Gross, and Revenue 81
9.6 AstraZeneca 82
9.6.1 Company Profile 82
9.6.2 Product Information 83
9.6.3 Sales, Price, Cost, Gross, and Revenue 83
9.7 Novartis 84
9.7.1 Company Profile 84
9.7.2 Product Information 85
9.7.3 Sales, Price, Cost, Gross, and Revenue 85
9.8 Shire 86
9.8.1 Company Profile 86
9.8.2 Product Information 87
9.8.3 Sales, Price, Cost, Gross, and Revenue 87
9.9 AbbVie 88
9.9.1 Company Profile 88
9.9.2 Product Information 89
9.9.3 Sales, Price, Cost, Gross, and Revenue 89
9.10 Ipsen 90
9.10.1 Company Profile 90
9.10.2 Product Information 91
9.10.3 Sales, Price, Cost, Gross, and Revenue 91
9.11 Allergan 92
9.11.1 Company Profile 92
9.11.2 Product Information 93
9.11.3 Sales, Price, Cost, Gross, and Revenue 93
9.12 Ferring 94
9.12.1 Company Profile 94
9.12.2 Product Information 95
9.12.3 Sales, Price, Cost, Gross, and Revenue 95
9.13 Merck 96
9.13.1 Company Profile 96
9.13.2 Product Information 97
9.13.3 Sales, Price, Cost, Gross, and Revenue 97
9.14 The Medicines 98
9.14.1 Company Profile 98
9.14.2 Product Information 99
9.14.3 Sales, Price, Cost, Gross, and Revenue 99
9.15 Roche 100
9.15.1 Company Profile 100
9.15.2 Product Information 101
9.15.3 Sales, Price, Cost, Gross, and Revenue 101
9.16 J & J 102
9.16.1 Company Profile 102
9.16.2 Product Information 103
9.16.3 Sales, Price, Cost, Gross, and Revenue 103
10 Peptide Therapeutics Manufacturing Cost Analysis 104
10.1 Peptide Therapeutics R&D Cost Analysis 104
10.1.1 Clinical Phase Costs 105
10.1.2 Capitalized Costs 106
10.2 Proportion of Manufacturing Cost Structure 107
10.2.1 Raw Materials 107
10.2.2 Labor Cost 109
10.2.3 Other Costs Analysis 113
10.3 Manufacturing Process Analysis of Peptide Therapeutics 119
11 Industrial Chain, Sourcing Strategy and Downstream Buyers 120
11.1 Peptide Therapeutics Industrial Chain Analysis 120
11.2 Upstream Raw Materials Sourcing 121
11.3 Downstream Buyers 121
12 Marketing Strategy Analysis, Distributors/Traders 124
12.1 Marketing Channel 124
12.1.1 Direct Marketing 124
12.1.2 Indirect Marketing 125
12.1.3 Marketing Channel Development Trend 126
12.2 Market Positioning 126
12.2.1 Pricing Strategy 126
12.2.2 Brand Strategy 128
12.3 Distributors/Traders List 129
13 Market Effect Factors Analysis 131
13.1 Technology Progress/Risk 131
13.1.1 Technology Progress 131
13.1.2 Peptide Cancer Vaccine by Pipeline 133
13.2 Consumer Needs/Customer Preference Change 145
13.2.1 Key Facts 145
13.2.2 Cancer Incidence and Mortality Analysis 146
13.3 Economic/Political Environmental Change 148
14 Global Peptide Therapeutics Market Forecast (2019-2025) 157
14.1 Global Peptide Therapeutics Sales, Revenue and Price Forecast (2019-2025) 157
14.1.1 Global Peptide Therapeutics Sales and Growth Rate Forecast (2019-2025) 157
14.1.2 Global Peptide Therapeutics Revenue and Growth Rate Forecast (2019-2025) 158
14.1.3 Global Peptide Therapeutics Price and Trend Forecast (2019-2025) 159
14.2 Global Peptide Therapeutics Sales, Revenue and Growth Rate Forecast by Regions (2019-2025) 159
14.2.1 Global Peptide Therapeutics Sales and Growth Rate Forecast by Regions (2019-2025) 159
14.2.2 Global Peptide Therapeutics Revenue and Growth Rate Forecast by Regions (2019-2025) 161
14.2.3 North America Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2025) 163
14.2.4 Europe Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2025) 164
14.2.5 China Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2025) 165
14.2.6 Japan Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2025) 166
14.2.7 India Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2025) 167
14.2.8 South America Peptide Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2025) 168
14.3 Global Peptide Therapeutics Sales Forecast by Type (2019-2025) 169
14.4 Global Peptide Therapeutics Revenue Forecast by Application (2019-2025) 169
15 Research Findings and Conclusion 171
16 Methodology and Data Source 173
16.1 Methodology/Research Approach 173
16.1.1 Research Programs/Design 173
16.1.2 Market Size Estimation 174
16.1.3 Market Breakdown and Data Triangulation 175
16.2 Data Source 176
16.2.1 Secondary Sources 176
16.2.2 Primary Sources 177
16.3 Disclaimer 178
16.4 Author List 179

Did you find apk for android? You can find new Free Android Games and apps.

Table & Fig

Want create site? Find Free WordPress Themes and plugins.

List of Tables and Figures

Figure Product Picture of Peptide Therapeutics 1
Table The Brands of Major Manufacturers 1
Table Peptide Drugs in the Global Market 2
Table Global Peptide Therapeutics Revenue (M USD) Comparison by Types (2013-2025) 3
Figure Global Peptide Therapeutics Revenue Market Share by Types in 2017 3
Figure Injection Product Picture 4
Figure Oral Product Picture 4
Table Global Peptide Therapeutics Revenue (M USD) Comparison by Applications (2013-2025) 5
Figure Global Revenue Market Share of Peptide Therapeutics by Applications in 2017 5
Figure Cancer Examples 6
Figure Metabolic Disorders Examples 6
Figure Central Nervous System Examples 7
Table Global Market Peptide Therapeutics Revenue (M USD) Comparison by Regions 2013-2025 7
Figure North America Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2025) 8
Figure Europe Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2025) 9
Figure China Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2025) 10
Figure Japan Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2025) 11
Figure India Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2025) 12
Figure South America Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2025) 13
Figure Global Peptide Therapeutics Sales (K Unit) and Growth Rate (2013-2025) 14
Figure Global Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2025) 15
Figure Lanreotide Revenue and Growth Rate2013-2025 15
Figure Liraglutide Revenue and Growth Rate 2013-2025 16
Table Global Peptide Therapeutics Sales (K Unit) of Key Players (2016-2017) 17
Table Global Peptide Therapeutics Sales Share (%) by Players (2016-2017) 18
Figure 2016 Global Peptide Therapeutics Sales Share (%) by Players 19
Figure 2017 Global Peptide Therapeutics Sales Share (%) by Players 20
Table Global Peptide Therapeutics Revenue (M USD) by Players (2016-2017) 20
Table Global Peptide Therapeutics Revenue Share (%) by Players (2016-2017) 21
Figure 2016 Global Peptide Therapeutics Revenue Share (%) by Players 22
Figure 2017 Global Peptide Therapeutics Revenue Share (%) by Players 23
Table Global Peptide Therapeutics Sales (K Unit) by Type (2013-2018) 24
Table Global Peptide Therapeutics Sales Share (%) by Type (2013-2018) 24
Figure Sales Market Share (%) of Peptide Therapeutics by Type (2013-2018) 25
Figure Global Peptide Therapeutics Sales Growth Rate by Type in 2017 25
Table Global Peptide Therapeutics Revenue (M USD) by Type (2013-2018) 26
Table Global Peptide Therapeutics Revenue Share (%) by Type (2013-2018) 26
Figure Revenue Market Share (%) of Peptide Therapeutics by Type (2013-2018) 26
Figure Global Peptide Therapeutics Revenue Growth Rate by Type in 2017 27
Table Global Peptide Therapeutics Sales (K Unit) by Regions (2013-2018) 27
Table Global Peptide Therapeutics Sales Share (%) by Regions (2013-2018) 28
Figure Sales Market Share (%) of Peptide Therapeutics by Regions (2013-2018) 28
Figure Global Peptide Therapeutics Sales Market Share (%) by Regions in 2017 29
Table Global Peptide Therapeutics Revenue (M USD) by Regions (2013-2018) 29
Table Global Peptide Therapeutics Revenue Share (%) by Regions (2013-2018) 29
Figure Revenue Market Share (%) of Peptide Therapeutics by Regions (2013-2018) 30
Figure Global Peptide Therapeutics Revenue Market Share (%) by Regions in 2017 31
Table Global Peptide Therapeutics Revenue (M USD) by Application (2013-2018) 31
Table Global Peptide Therapeutics Revenue Share (%) by Application (2013-2018) 31
Figure Revenue Market Share (%) of Peptide Therapeutics by Application (2013-2018) 32
Figure Global Peptide Therapeutics Revenue Market Share (%) by Application in 2017 33
Figure North America Peptide Therapeutics Sales (K Unit) and Growth Rate (%) (2013-2018) 34
Figure North America Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2018) 35
Figure North America Peptide Therapeutics Price (USD/Unit) Trend (2013-2018) 36
Table North America Peptide Therapeutics Revenue (M USD) by Players (2016-2017) 36
Table North America Peptide Therapeutics Revenue Market Share (%) by Players (2016-2017) 37
Figure North America Peptide Therapeutics Sales (K Unit) Market Share (%) by Players in 2017 38
Table North America Peptide Therapeutics Revenue (M USD) by Type (2013-2018) 38
Table North America Peptide Therapeutics Revenue Market Share (%) by Type (2013-2018) 39
Figure North America Peptide Therapeutics Revenue Market Share (%) by Type in 2017 39
Table North America Peptide Therapeutics Revenue (M USD) by Application (2013-2018) 39
Table North America Peptide Therapeutics Revenue Market Share (%) by Application (2013-2018) 40
Figure North America Peptide Therapeutics Revenue Market Share (%) by Application in 2017 40
Figure China Peptide Therapeutics Sales (K Unit) and Growth Rate (2013-2018) 41
Figure China Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2018) 42
Figure China Peptide Therapeutics Price (USD/Unit) Trend (2013-2018) 42
Table China Peptide Therapeutics Revenue (M USD) by Players (2016-2017) 43
Table China Peptide Therapeutics Revenue Market Share (%) by Players (2016-2017) 43
Figure China Peptide Therapeutics Revenue Market Share (%) by Players in 2017 44
Table China Peptide Therapeutics Revenue (M USD) by Type (2013-2018) 44
Table China Peptide Therapeutics Revenue Market Share (%) by Type (2013-2018) 44
Figure China Peptide Therapeutics Revenue Market Share (%) by Type in 2017 45
Table China Peptide Therapeutics Revenue (M USD) by Application (2013-2018) 45
Table China Peptide Therapeutics Revenue Market Share (%) by Application (2013-2018) 45
Figure China Peptide Therapeutics Revenue Market Share (%) by Application in 2017 46
Figure Europe Peptide Therapeutics Sales (K Unit) and Growth Rate (2013-2018) 47
Figure Europe Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2018) 48
Figure Europe Peptide Therapeutics Price (USD/Unit) Trend (2013-2018) 48
Table Europe Peptide Therapeutics Revenue (M USD) by Players (2016-2017) 49
Table Europe Peptide Therapeutics Revenue Market Share (%) by Players (2016-2017) 49
Figure Europe Peptide Therapeutics Revenue Market Share (%) by Players in 2017 50
Table Europe Peptide Therapeutics Revenue (M USD) by Type (2013-2018) 50
Table Europe Peptide Therapeutics Revenue Market Share (%) by Type (2013-2018) 51
Figure Europe Peptide Therapeutics Revenue Market Share (%) by Type in 2017 51
Table Europe Peptide Therapeutics Revenue (M USD) by Application (2013-2018) 52
Table Europe Peptide Therapeutics Revenue Market Share (%) by Application (2013-2018) 52
Figure Europe Peptide Therapeutics Revenue Market Share (%) by Application in 2017 53
Figure Japan Peptide Therapeutics Sales (K Unit) and Growth Rate (2013-2018) 54
Figure Japan Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2018) 55
Figure Japan Peptide Therapeutics Price (USD/Unit) Trend (2013-2018) 55
Table Japan Peptide Therapeutics Revenue (M USD) by Players (2016-2017) 56
Table Japan Peptide Therapeutics Revenue Market Share (%) by Players (2016-2017) 56
Figure Japan Peptide Therapeutics Revenue Market Share (%) by Players in 2017 57
Table Japan Peptide Therapeutics Revenue (M USD) by Type (2013-2018) 57
Table Japan Peptide Therapeutics Revenue Market Share (%) by Type (2013-2018) 57
Figure Japan Peptide Therapeutics Revenue Market Share (%) by Type in 2017 58
Table Japan Peptide Therapeutics Revenue (M USD) by Application (2013-2018) 58
Table Japan Peptide Therapeutics Revenue Market Share (%) by Application (2013-2018) 59
Figure Japan Peptide Therapeutics Revenue Market Share (%) by Application in 2017 59
Figure India Peptide Therapeutics Sales (K Unit) and Growth Rate (2013-2018) 60
Figure India Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2018) 61
Figure India Peptide Therapeutics Price (USD/Unit) Trend (2013-2018) 61
Table India Peptide Therapeutics Revenue (M USD) by Players (2016-2017) 62
Table India Peptide Therapeutics Revenue Market Share (%) by Players (2016-2017) 62
Figure India Peptide Therapeutics Revenue Market Share (%) by Players in 2017 63
Table India Peptide Therapeutics Revenue (M USD) by Type (2013-2018) 63
Table India Peptide Therapeutics Revenue Market Share (%) by Type (2013-2018) 63
Figure India Peptide Therapeutics Revenue Market Share (%) by Type in 2017 64
Table India Peptide Therapeutics Revenue (M USD) by Application (2013-2018) 64
Table India Peptide Therapeutics Revenue Market Share (%) by Application (2013-2018) 64
Figure India Peptide Therapeutics Revenue Market Share (%) by Application in 2017 65
Figure South America Peptide Therapeutics Sales (K Unit) and Growth Rate (2013-2018) 66
Figure South America Peptide Therapeutics Revenue (M USD) and Growth Rate (2013-2018) 67
Figure South America Peptide Therapeutics Price (USD/Unit) Trend (2013-2018) 67
Table South America Peptide Therapeutics Revenue (M USD) by Players (2016-2017) 68
Table South America Peptide Therapeutics Revenue Market Share (%) by Players (2016-2017) 68
Figure South America Peptide Therapeutics Revenue Market Share (%) by Players in 2017 69
Table South America Peptide Therapeutics Revenue (M USD) by Type (2013-2018) 69
Table South America Peptide Therapeutics Revenue Market Share (%) by Type (2013-2018) 70
Figure South America Peptide Therapeutics Revenue Market Share (%) by Type in 2017 70
Table South America Peptide Therapeutics Revenue (M USD) by Application (2013-2018) 70
Table South America Peptide Therapeutics Revenue Market Share (%) by Application (2013-2018) 71
Figure South America Peptide Therapeutics Revenue Market Share (%) by Application in 2017 71
Table Sanofi Company Profile 72
Figure Peptide Therapeutics Product Picture of Sanofi 73
Table Peptide Therapeutics Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2016-2017 73
Table Teva Company Profile 74
Figure Peptide Therapeutics Product Picture of Teva 75
Table Peptide Therapeutics Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Teva 2016-2017 75
Table Novo Nordisk Company Profile 76
Figure Peptide Therapeutics Product Picture of Novo Nordisk 77
Table Peptide Therapeutics Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novo Nordisk 2016-2017 77
Table Takeda Company Profile 77
Figure Peptide Therapeutics Product Picture of Takeda 79
Table Peptide Therapeutics Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Takeda 2016-2017 79
Table Eli Lilly Company Profile 80
Figure Peptide Therapeutics Product Picture of Eli Lilly 81
Table Peptide Therapeutics Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Eli Lilly 2016-2017 81
Table AstraZeneca Company Profile 82
Figure Peptide Therapeutics Product Picture of AstraZeneca 83
Table Peptide Therapeutics Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of AstraZeneca 2016-2017 83
Table Novartis Company Profile 84
Figure Peptide Therapeutics Product Picture of Novartis 85
Table Peptide Therapeutics Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2016-2017 85
Table Shire Company Profile 86
Figure Peptide Therapeutics Product Picture of Shire 87
Table Peptide Therapeutics Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Shire 2016-2017 87
Table AbbVie Company Profile 88
Figure Peptide Therapeutics Product Picture of AbbVie 89
Table Peptide Therapeutics Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of AbbVie 2016-2017 89
Table Ipsen Company Profile 90
Figure Peptide Therapeutics Product Picture of Ipsen 91
Table Peptide Therapeutics Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Ipsen 2016-2017 91
Table Allergan Company Profile 92
Figure Peptide Therapeutics Product Picture of Allergan 93
Table Peptide Therapeutics Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Allergan 2016-2017 93
Table Ferring Company Profile 94
Figure Peptide Therapeutics Product Picture of Ferring 95
Table Peptide Therapeutics Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Ferring 2016-2017 95
Table Merck Company Profile 96
Figure Peptide Therapeutics Product Picture of Merck 97
Table Peptide Therapeutics Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Merck 2016-2017 97
Table The Medicines Company Profile 98
Figure Peptide Therapeutics Product Picture of The Medicines 99
Table Peptide Therapeutics Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of The Medicines 2016-2017 99
Table Roche Company Profile 100
Figure Peptide Therapeutics Product Picture of Roche 101
Table Peptide Therapeutics Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Roche 2016-2017 101
Table J & J Company Profile 102
Figure Peptide Therapeutics Product Picture of J & J 103
Table Peptide Therapeutics Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of J & J 2016-2017 103
Figure typical phases from research to the market for a drug candidate 105
Table Out-of-pocket Preclinical and Clinical Period Cost Per Investigational Biopharmaceutical Compound 106
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound 107
Figure Manufacturing Cost Structure of Peptide Therapeutics 107
Figure Assessment of API Manufacturing Cost by Region 108
Figure USA Labor Cost Analysis 2012-2016 109
Figure Cost of Employing a Factory Worker 110
Figure 2016 Estimated Labour Costs for the Whole Economy in Europe 111
Figure Monthly Minimum Wages in Asia 2016 112
Figure China Labor Costs 2013-2016 112
Table Average Price of Electricity to Ultimate Customers 2007-2016 113
Figure Electricity Prices for Household Consumers in 2016 115
Figure Summary of the Driving Assumptions 116
Figure Industrial Electric Rates 2016 (PER KWH) 117
Figure Manufacturing Process Analysis of Peptide Therapeutics 119
Figure Peptide Therapeutics Industrial Chain Analysis 120
Table Major Buyers of Peptide Therapeutics 121
Figure Market Channel of Peptide Therapeutics 126
Figure Setting Pricing Policy 127
Table Distributors/Traders List 129
Table GLP-1 Agonists Currently in Clinical or Preclinical Testing 131
Table SWOT Analysis of Peptides as Ttherapeutics 132
Figure Product Picture of Peptide Cancer Vaccine 133
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 134
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 134
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 135
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 135
Figure UV1 Technology 137
Figure How HER-Vaxx is Tntended to Work 141
Figure Molecular Modeling Study-MHC Class II Receptor 144
Figure Li Suppression 144
Figure Li-KEY Hybrid 145
Figure Cancer Incidence by Country in 2016 146
Figure Cancer Mortality by Country in 2016 147
Figure USA numbers of new cancer cases for 2016 147
Figure Global GDP Growth Rate for 2016 148
Figure Real GDP Growth 2016-2020 annual Average 149
Figure US GDP 2006-2016 (Billion USD) 150
Figure US CPI Change 2016-2017 150
Figure EU GDP 2006-2016 (Billion USD) 151
Figure EU CPI Change 2012-2016 151
Figure Germany GDP 2006-2016 (Billion USD) 152
Figure Germany CPI Change 2016-2017 152
Figure UK GDP 2006-2016 (Billion USD) 152
Figure UK CPI Change 2016-2017 153
Figure Italy GDP 2006-2016 (Billion USD) 153
Figure Italy CPI Change 2016-2017 154
Figure Japan GDP 2006-2016 (Billion USD) 154
Figure Japan CPI Change 2012-2016 155
Figure China GDP 2006-2016 (Billion USD) 155
Figure China CPI Change 2016-2017 156
Figure Global Peptide Therapeutics Sales (K Unit) and Growth Rate Forecast (2019-2025) 157
Figure Global Peptide Therapeutics Revenue (M USD) and Growth Rate Forecast (2019-2025) 158
Figure Global Peptide Therapeutics Price (USD/Unit) and Trend Forecast (2019-2025) 159
Table Global Peptide Therapeutics Sales (K Unit) Forecast by Regions (2019-2025) 159
Figure Global Peptide Therapeutics Sales Market Share (%) Forecast by Regions (2019-2025) 160
Figure Global Peptide Therapeutics Sales Market Share (%) Forecast by Regions in 2025 161
Table Global Peptide Therapeutics Revenue (M USD) Forecast by Regions (2019-2025) 161
Figure Global Peptide Therapeutics Revenue Market Share (%) Forecast by Regions (2019-2025) 162
Figure Global Peptide Therapeutics Revenue Market Share (%) Forecast by Regions in 2025 162
Figure North America Peptide Therapeutics Sales (K Unit) and Growth Rate (%) Forecast (2019-2025) 163
Figure North America Peptide Therapeutics Revenue (M USD) and Growth Rate Forecast (2019-2025) 163
Figure Europe Peptide Therapeutics Sales (K Unit) and Growth Rate (%) Forecast (2019-2025) 164
Figure Europe Peptide Therapeutics Revenue (M USD) and Growth Rate Forecast (2019-2025) 164
Figure China Peptide Therapeutics Sales (K Unit) and Growth Rate (%) Forecast (2019-2025) 165
Figure China Peptide Therapeutics Revenue (M USD) and Growth Rate Forecast (2019-2025) 165
Figure Japan Peptide Therapeutics Sales (K Unit) and Growth Rate (%) Forecast (2019-2025) 166
Figure Japan Peptide Therapeutics Revenue (M USD) and Growth Rate Forecast (2019-2025) 166
Figure India Peptide Therapeutics Sales (K Unit) and Growth Rate (%) Forecast (2019-2025) 167
Figure India Peptide Therapeutics Revenue (M USD) and Growth Rate Forecast (2019-2025) 167
Figure South America Peptide Therapeutics Sales (K Unit) and Growth Rate (%) Forecast (2019-2025) 168
Figure South America India Peptide Therapeutics Revenue (M USD) and Growth Rate Forecast (2019-2025) 168
Table Global Peptide Therapeutics Sales (K Unit) Forecast by Type (2019-2025) 169
Figure Global Peptide Therapeutics Sales Market Share (%) Forecast by Type in 2025 169
Table Global Peptide Therapeutics Revenue (M USD) Forecast by Application (2019-2025) 169
Figure Global Peptide Therapeutics Revenue Market Share (%) Forecast by Application in 2025 170
Table Research Programs/Design for This Report 173
Figure Bottom-up and Top-down Approaches for This Report 175
Figure Data Triangulation 176
Table Key Data Information from Secondary Sources 177
Table Key Data Information from Primary Sources 178

Did you find apk for android? You can find new Free Android Games and apps.

Report Enquiry

Did you find apk for android? You can find new Free Android Games and apps.